| abstract |
This invention features the use of human intestinal trefoil peptide for the manufacture of a medicament for the treatment or prevention of lesions of the vaginal, cervical, or uterine epithelium of a mammal. The intestinal trefoil peptide can be administered either alone or in combination with one or therapeutic agents. According to a preferred embodiment said intestinal trefoil peptide is spasmolytic polypeptide, pS2, intestinal trefoil factor (ITF), ITF 15-73 , ITF 21-73 , ITF 1-72 , ITF 15-72 , or ITF 21-72 . |